Non-Binary and Low-Dose HRT Options

Not everyone who pursues hormone therapy wants a fully feminising or fully masculinising result. Many non-binary, genderqueer, and gender-fluid individuals seek a more androgynous outcome. Gender Journey supports you whatever your goals.

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult with your healthcare provider before making any changes to your medication.

What Is Androgynous HRT?

Androgynous or non-binary HRT refers to hormone therapy approaches that aim for a balance between traditionally masculine and feminine characteristics, rather than moving fully in one direction. This is a highly individual process and requires close collaboration with your healthcare provider.

Common Approaches

Low-Dose Oestrogen

Taking oestrogen at lower doses can produce subtler feminising changes. This approach may lead to:

• Mild skin softening.
• Some breast development (typically less than standard doses).
• Gradual fat redistribution.

The pace and extent of changes depend on the dose, duration, and your individual biology.

Low-Dose Testosterone

Similarly, low-dose testosterone can produce milder masculinising changes:

• Mild voice deepening.
• Some increase in body hair.
• Gradual changes in fat distribution.

Some changes from testosterone (like voice deepening) may be permanent even at low doses, so it is important to discuss this with your provider before starting.

Selective Use of Blockers

Some individuals use GnRH analogues or anti-androgens without adding cross-sex hormones. This can reduce the effects of your body's dominant hormone without introducing the effects of another. Options include:

• GnRH analogues (e.g., leuprolide, goserelin, triptorelin) — Suppress the body's hormone production.
• Anti-androgens (e.g., spironolactone, cyproterone) — Block testosterone effects specifically.
• 5α-reductase inhibitors (e.g., finasteride) — Block DHT conversion without affecting testosterone levels broadly.

Combination Approaches

Some people combine low-dose hormones with selective blockers to fine-tune their results. For example, a low dose of oestrogen with an anti-androgen, or a low dose of testosterone combined with a 5α-reductase inhibitor to limit certain androgenic effects.

Important Considerations

• Changes vary — Individual responses to low-dose HRT are less predictable than standard-dose regimens.
• Some changes are irreversible — Voice deepening (testosterone) and breast development (oestrogen) may be permanent.
• Monitoring is essential — Regular blood tests are just as important on low-dose regimens as on standard doses.
• Communication — Work closely with a healthcare provider experienced in non-binary HRT.

Tracking Your Journey

Gender Journey supports all these approaches. Log any combination of medications in My Medications, track your blood tests in My Health, and document your changes with My Photos and My Diary.